
The authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.
Zhiqi Hao is biopharma program manager at Thermo Fisher Scientific, San Jose, CA, USA.

The authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.

Published: July 15th 2013 | Updated: